| Ms Walda Lynne Ciafone, MSW | |
|
6600 81st St, Cabin John, MD 20818-1205 | |
| (301) 229-7201 | |
| Not Available |
| Full Name | Ms Walda Lynne Ciafone |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 6600 81st St, Cabin John, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427328855 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 04150 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Walda Lynne Ciafone, MSW 6600 81st St, Cabin John, MD 20818-1205 Ph: (301) 229-7201 | Ms Walda Lynne Ciafone, MSW 6600 81st St, Cabin John, MD 20818-1205 Ph: (301) 229-7201 |
News Archive
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced the expansion of its collaboration with the U.S. Government to include the evaluation of Restanza's activity against sexually transmitted infections (STI's), such as gonorrhea.
Vagus nerve stimulation (VNS) therapy, a treatment recently approved by the Food and Drug Administration for treatment-resistant depression, produced a positive response in more than 25 percent of patients in a national, yearlong study led by UT Southwestern Medical Center psychiatrists
N30 Pharmaceuticals, Inc. announced today that it has begun oral dosing of N91115 in a Phase 1 clinical trial. N91115, a novel inhibitor of S-nitrosoglutathione reductase (GSNOR), is being developed for the treatment of cystic fibrosis (CF).
The Centers for Medicare & Medicaid Services is making this information available for the first time in 35 years. Meanwhile, in their first run at the data, news outlets report that a small number of doctors account for a large share of Medicare costs.
Medicago Inc. (TSX: MDG; OTCQX: MDCGF), a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced the successful production of a Rotavirus VLP vaccine candidate comprising all four structural antigens of rotavirus (VP2, VP4, VP6 and VP7) using Medicago's plant-based manufacturing platform.
› Verified 7 days ago
Marian Hwang, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 7945 Macarthur Blvd Ste 214, Cabin John, MD 20818 Phone: 301-987-7284 | |
Ethel Doris Sayles, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 6500 Seven Locks Rd Ste 206, Cabin John, MD 20818 Phone: 301-514-6920 | |
Lori Rieckelman, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 6423 79th St, Cabin John, MD 20818 Phone: 301-655-4404 | |
Ms. Jan Iris Smith, LCSW,BCD Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 6502 78th St, Cabin John, MD 20818 Phone: 301-320-4825 | |
Harry Rieckelman, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 6423 79th St, Cabin John, MD 20818 Phone: 301-655-4403 | |
Elizabeth Michelle Lawler, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 7945 Macarthur Blvd Ste 214, Cabin John, MD 20818 Phone: 301-987-7284 |